Presentation TCT 2012 RESET 2-Year: A Prospective, Randomized Trial of Everolimus-Eluting vs. Sirolimus-Eluting Stents Presenter: Ken Kozuma October 25, 2012 REGISTER for free or LOG IN to view this content DES/BRS/DCB Presentation TCT 2012 Up Next Presentation TCT 2012 Cerebral Embolic Protection during TAVR: Metrics for Evaluating Safety and Efficacy Presenter: Martyn Thomas October 25, 2012 More slides + Presentation TCT 2012 Plasmonic Photothermal Therapy of Atherosclerotic Lesions with Silica-Gold Nanoparticles Presenter: Alexander Kharlamov October 22, 2012 Presentation TCT 2012 If You Want the Truth, Randomize! Presenter: Robert Harrington October 24, 2012 We Recommend
Presentation TCT 2012 Cerebral Embolic Protection during TAVR: Metrics for Evaluating Safety and Efficacy Presenter: Martyn Thomas October 25, 2012
Presentation TCT 2012 Plasmonic Photothermal Therapy of Atherosclerotic Lesions with Silica-Gold Nanoparticles Presenter: Alexander Kharlamov October 22, 2012
Presentation TCT 2012 If You Want the Truth, Randomize! Presenter: Robert Harrington October 24, 2012